About Citius Pharmaceuticals Inc. Common
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
Market Cap
$0.01B
Employees
23
Listed Since
October 18, 2011
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.citiuspharma.comPhone
(908) 967-6676
Headquarters
11 COMMERCE DRIVE
CRANFORD, NJ 07016
CIK
0001506251